SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
-8.88%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$568M
AUM Growth
+$568M
(-15%)
Cap. Flow
-$10.3M
Cap. Flow
% of AUM
-1.81%
Top 10 Holdings %
Top 10 Hldgs %
41.82%
Holding
155
New
29
Increased
27
Reduced
41
Closed
33
Top Buys
| 1 |
Teva Pharmaceuticals
TEVA
|
$32.5M |
| 2 |
Elbit Systems
ESLT
|
$29.2M |
| 3 |
Incyte
INCY
|
$11M |
| 4 |
CEL
Cellcom Israel, Ltd.
CEL
|
$8.79M |
| 5 |
Biogen
BIIB
|
$7.08M |
Top Sells
| 1 |
Merck
MRK
|
$22.8M |
| 2 |
Gilead Sciences
GILD
|
$19.6M |
| 3 |
Pfizer
PFE
|
$9.42M |
| 4 |
CXRX
Concordia International Corp. Common Stock
CXRX
|
$9.03M |
| 5 |
Verint Systems
VRNT
|
$8.47M |
Sector Composition
| 1 | Healthcare | 76.98% |
| 2 | Industrials | 5.61% |
| 3 | Utilities | 3.5% |
| 4 | Technology | 1.75% |
| 5 | Consumer Discretionary | 1.27% |